Fig. 6From: Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturingFinal titer and in-process quality attributes with combined data of mAb1 and mAb3 for Process B (n = 7) and Process C (n = 4). In order to make statistical analysis more effective, average final titer, main peak, G0F, and monomer for Process C at 500-L scale was normalized as 1 for mAb1 and mAb3, respectivelyBack to article page